State Street SPDR SandP Pharmaceuticals ETF (XPH) |
| 68.01 -1.31 (-1.89%) 09-10 16:00 |
| Open: | 68.71 |
| High: | 69.0551 |
| Low: | 67.91 |
| Volume: | 149,096 |
| Market Cap: | 274(M) |
| PE Ratio: | 17.98 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 74.35 |
| Resistance 1: | 71.89 |
| Pivot price: | 71.28 |
| Support 1: | 67.91 |
| Support 2: | 56.50 |
| 52w High: | 74.35 |
| 52w Low: | 45.8 |
SPDR Series Trust - SPDR S&P Pharmaceuticals ETF is an exchange traded fund launched by State Street Global Advisors, Inc. It is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. The fund invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Pharmaceuticals Select Industry Index, by using representative sampling technique. SPDR Series Trust - SPDR S&P Pharmaceuticals ETF was formed on June 16, 2006 and is domiciled in the United States.
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Thu, 10 Sep 2026
Better Healthcare ETF: Vanguard's VHT vs. State Street's Pharmaceuticals-Focused XPH - The Motley Fool
Thu, 10 Sep 2026
Which Healthcare ETF Is the Better Buy: Fidelity's Broad FHLC or State Street's Pharma-Focused XPH? - The Motley Fool
Tue, 08 Sep 2026
Is State Street SPDR S&P Homebuilders ETF (XHB) a Strong ETF Right Now? - Yahoo Finance
Sat, 22 Aug 2026
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? - Eastern Progress
Wed, 19 Aug 2026
Healthcare ETFs Are Looking Up: Here's Why - TradingView
Mon, 17 Aug 2026
XPH vs PJP: Which Pharma ETF Offers Better Value - The Motley Fool
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |